Cargando...

P2X-Selective Purinergic Antagonists Are Strong Inhibitors of HIV-1 Fusion during both Cell-to-Cell and Cell-Free Infection

Human immunodeficiency virus type 1 (HIV-1) infection is chronic and presently still incurable. Antiretroviral drugs effectively suppress replication; however, persistent activation of inflammatory pathways remains a key cause of morbidity. Recent studies proposed that purinergic signaling is requir...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Swartz, Talia H., Esposito, Anthony M., Durham, Natasha D., Hartmann, Boris M., Chen, Benjamin K.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4178786/
https://ncbi.nlm.nih.gov/pubmed/25031337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01158-14
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!